Anondita Medicare
add_icon

Anondita Medicare

935.75
-2.40
(-0.26%)
Market Cap
1,692.46 Cr
PE Ratio
103.32
Volume
1,800.00
Day High - Low
940.00 - 929.05
52W High-Low
1,227.00 - 261.75
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
1,692.46 Cr
EPS
14.04
PE Ratio
103.32
PB Ratio
15.80
Book Value
59.36
EBITDA
25.80
Dividend Yield
0.00 %
Return on Equity
42.04
Debt to Equity
0.72
Forecast For
Actual

Company News

View All News
Caret
positive
Anondita Medicare Limited will participate in Pharma Eurasia 2026 in Tashkent, Uzbekistan, from May 20–22, 2026, to expand its Central Asian market presence and explore business opportunities.
neutral
Anondita Medicare Limited published its EGM notice in Financial Express and Jansatta on May 7, 2026, per Regulation 30, ahead of the May 28, 2026 meeting via VC/OAVM.
positive
Anondita Medicare Reports Strong H1 Performance with 117% Revenue GrowthNov 13, 2025
Anondita Medicare delivered robust H1 results with net profit surging to 130M rupees from 60M rupees year-over-year, while revenue jumped to 541M rupees from 314M rupees. The company's EBITDA increased to 192M rupees from 97M rupees, with EBITDA margin improving to 35.49% from 30.95%.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,033.30
#1 1,05,731.86
56.71
#1 15,100.10
2.86
#1 1,985
9.69
42.33
464.75
82,432.25
43.93
13,192.60
0.61
1,883
15.77
54.12
2,146.60
58,384.44
43.73
6,179.00
7.33
1,437
0.34
56.74
9,635.00
31,275.92
36.48
3,411.80
-19.87
637
12.25
35.87
7,864.00
25,625.01
41.44
2,262.80
-14.91
418
36.90
46.61
424.50
18,529.43
#1 23.55
3,877.30
6.96
803
14.52
39.59
123.08
16,550.08
197.10
203.20
13.97
41
#1 195.50
61.63
352.90
11,482.30
72.52
2,145.70
8.94
73
93.08
62.88
518.45
6,771.91
36.11
1,153.43
#1 15.30
190
105.16
63.92
935.75
#10 1,692.46
#9 103.32
#10 77.10
-
#10 16
-
47.80
Growth Rate
Revenue Growth
-
Net Income Growth
-
Cash Flow Change
-181.67 %
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-

Yearly Financial Results

Annual Financials
2025
TTM
Revenue
77
0
Expenses
51
0
EBITDA
26
0
Operating Profit %
33 %
0 %
Depreciation
1
0
Interest
3
0
Profit Before Tax
22
0
Tax
6
0
Net Profit
16
0
EPS in ₹
14.04
0.00

Balance Sheet

Balance Sheet
2025
Total Assets
78
Fixed Assets
14
Current Assets
55
Capital Work in Progress
7
Investments
0
Other Assets
58
Total Equity & Liabilities
78
Current Liabilities
27
Non Current Liabilities
12
Total Equity
39
Reserve & Surplus
25
Share Capital
13

Cash Flow

Cash Flow
2025
Net Cash Flow
-0
Investing Activities
-23
Operating Activities
-11
Financing Activities
33

Share Holding

% Holding
Dec 2024
Aug 2025
Sept 2025
Mar 2026
Promoter
83.95 %
61.71 %
61.79 %
62.40 %
FIIs
0.00 %
0.00 %
0.00 %
3.40 %
DIIs
0.00 %
0.65 %
0.00 %
5.70 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
21.42 %
17.13 %
18.84 %
Others
16.05 %
16.22 %
21.08 %
9.65 %
No of Share Holders
57
86
621
530

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
28 May 2026 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
28 May 2026 1,020.30 938.15
13 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2025 600.20 605.00
12 Feb 2026 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
12 Feb 2026 952.85 825.10

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
WhiteOak Capital Balanced Hybrid Fund Direct-Growth
0.00%
0
0.00%
0.00%

Technical Indicators

RSI(14)
Neutral
48.10
ATR(14)
Less Volatile
46.09
STOCH(9,6)
Oversold
10.15
STOCH RSI(14)
Oversold
3.35
MACD(12,26)
Bearish
-22.12
ADX(14)
Weak Trend
24.68
UO(9)
Bearish
42.69
ROC(12)
Downtrend And Accelerating
-21.16
WillR(14)
Oversold
-95.65